Amphastar Pharma Q1 2024 Adj EPS $1.04 Beats $0.77 Estimate, Sales $171.800M Miss $174.713M Estimate
Amphastar Pharma Q1 2024 Adj EPS $1.04 Beats $0.77 Estimate, Sales $171.800M Miss $174.713M Estimate
Amphastar Pharma 2024年第一季度調整後每股收益1.04美元高於0.77美元的預期，銷售額爲1.718億美元，低於1.74713億美元的預期
Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $0.77 by 35.06 percent. The company reported quarterly sales of $171.800 million which missed the analyst consensus estimate of $174.713 million by 1.67 percent. This is a 22.70 percent increase over sales of $140.022 million the same period last year.
Amphastar Pharma（納斯達克股票代碼：AMPH）公佈的季度收益爲每股1.04美元，比分析師普遍預期的0.77美元高出35.06％。該公司公佈的季度銷售額爲1.718億美元，比分析師普遍預期的1.74713億美元低1.67％。這比去年同期的1.4022億美元的銷售額增長了22.70％。